Smiling vet holding smiling dog
Zoetis Adds Digital Cytology Testing To VETSCAN IMAGYST™, Its All-In-One Diagnostics Technology Platform
Zoetis continues to advance innovation in diagnostics, announcing the addition of Digital Cytology testing to its VETSCAN IMAGYST™ platform, which was introduced in September 2020 in the UK, Canada, European Union, and Australia.
With the launch of digital cytology, VETSCAN IMAGYST now offers a network of expert remote pathologists in addition to AI technology for fecal testing. As Zoetis continues to develop innovative solutions for VETSCAN IMAGYST, new capabilities will be seamlessly integrated, helping veterinarians provide the best possible care for dogs and cats.
“Veterinarians have told us that VETSCAN IMAGYST technology helps them make better informed decisions in a more transparent way for pet owners,” said Jamie Brannan, President International Operations, Zoetis. “With the cytology feature, VETSCAN IMAGYST will now offer one platform for multiple tests.”
The addition of digital cytology to VETSCAN IMAGYST is just one example of Zoetis’ enduring commitment to innovation and relentless drive to help veterinarians provide ever better care to cats and dogs. VETSCAN IMAGYST is at the forefront of in-clinic diagnostics and will continue to evolve with advanced solutions that make a meaningful difference for veterinarians, their patients, and pet owners.
The digital cytology application from VETSCAN IMAGYST is the new, convenient approach to expert pathology. With fast, accurate review of common cytology specimens, such as fine-needle aspirates, VETSCAN IMAGYST helps veterinarians provide the best possible care with same-day diagnosis and treatment, if necessary. VETSCAN IMAGYST accelerates the process for expert clinical pathology review, providing results within hours. Submissions are prepared in-clinic using traditional methods, but submitted digitally, rather than sending physical slides to a laboratory.
“We are excited to build on the incredible momentum that began with the AI fecal analysis launch,” said Jamie Brannan. “VETSCAN IMAGYST has been a significant part of the Zoetis portfolio and continues to evolve to meet diagnostic needs in practices around the world. The unique all-in-one technology has added immense value to veterinary clinics, facilitating fast, more accurate results, leading to quicker diagnoses and decisions that ultimately strengthen the bond of trust between veterinarians and their clients.”
Talk to your Zoetis representative to learn more about VETSCAN IMAGYST or visit us at www.VetscanImagyst.com.
More from Zoetis
- Zoetis selected for OIE Rabies Vaccine Bank
- Zoetis hosts free Equine Worm Control Webinar for RAMAs/SQPs, Vets and Vet Nurses
- Using the wrong wormer can increase the risk of potentially fatal disease
- Zoetis Receives European Commission Marketing Authorization for APOQUEL® chewable tablets (oclacitinib) for the treatment of itch and inflammation in allergic dogs
- Exclusive Video Series with Mary King and Ros Canter in Conversation on HorseDialog